Additional Amount?So I guess this potential additional amount will depend on how they view the results below. Based on the highlights, it looks pretty good. GLTA
and an additional earnout of up to CAD $0.45 per Aveda common share (if any, the “Earnout”) contingent on Aveda achieving certain EBITDA targets (the “Transaction”).
Generated Adjusted EBITDA1 of $3.6 million for the three months ended December 31, 2017. This amount of Adjusted EBITDA1 continues the strong performance the Company has experienced throughout fiscal 2017. Adjusted EBITDA1 in the fourth quarter of 2017 increased by $3.0 million or almost 500% compared to $0.6 million in the fourth quarter of 2016;